Skip to content

Naturopathic Treatment of Rotator Cuff Tendonitis Amongst Postal Workers, a randomized controlled parallel group study

Naturopathic Treatment of Rotator Cuff Tendonitis Amongst Postal Workers, a randomized controlled parallel group study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN49884134
Enrollment
80
Registered
2007-03-28
Start date
2007-02-01
Completion date
Unknown
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator cuff tendonitis Musculoskeletal Diseases tendonitis

Interventions

Supplement containing bromelain, rutin, and trypsin, and acupuncture vs placebo supplement with assisted, active, and resisted range of motion exercise

Sponsors

The Canadian College of Naturopathic Medicine (Canada)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Males and females aged 18-65 2. Mentally competent subjects able to adhere to the given protocol and treatments administered as interventions 3. Self-selected candidates identifying themselves to suffer from pain in at least one shoulder for a period of 6 weeks or more 4. Normal on physical examination at the pre-study intake, and in the case of abnormalities the medical practitioner considers them to be clinically insignificant 5. Written and informed consent 6. The potential candidate must have a family doctor that they have seen in the last 12 months 7. A negative pregnancy test for menstruating women and a willingness to practice adequate birth control for the duration of the trial 8. Symptoms consistent with rotator cuff tendonitis, as determined by medical history or examination at screening

Exclusion criteria

Exclusion criteria: 1. Mentally or physically incapacitated such that informed consent cannot be obtained 2. Any history or other condition which the study physician regards as clinically significant to the study 3. A major illness considered to be clinically significant by the study physician within 3 months of the study start date 4. Current participation in another intervention trial 5. Pregnancy or intent to become pregnant in the next 6 months 6. Medication at doses that is contraindicated with supplement (specifically daily use of warfarin, high dose aspirin, other blood thinners, or antibiotics) 7. Current alcoholism or substance abuse 8. Current history of tumors 9. Any current serious disorders determined to be clinically significant to the study 10. Breast feeding women 11. No prior shoulder surgeries, or scheduled surgeries of any kind 12. Haemophiliac, suffering from severe liver damage, or suffering from any hemorrhagic disease 13. Major shoulder joint pathology on assessment including full tendon rupture or degenerative joint disease. In these cases, referral for further evaluation and diagnosis will occur 14. Subjects with known sensitivity to any ingredient in the test product or to any member of the Bromeliaceae family, including pineapple 15. Subjects using Natural Health Products (NHPs) for 2 weeks prior to enrolment which affect shoulder pain or inflammation, contain phlogenzym or therapeutic constituents of the diet in supplement form 16. Current use of corticosteroid injection therapy

Design outcomes

Primary

MeasureTime frame
Shoulder Pain And Disability Index (SPADI)

Secondary

MeasureTime frame
1. 36-item short form general health questionnaire (SF-36) 2. Shoulder range of movement 3. Orthopaedic shoulder tests

Countries

Canada

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026